FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileEZZ Life Science Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
EZZ.AX
EZZ Life Science Holdings Limited Stock AnalysisComprehensive stock analysis for EZZ Life Science Holdings Limited (EZZ.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisEZZ.AX
EZZ.AX
EZZ Life Science Holdings Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
EZZ.AX
  1. Home
  2. Stocks
  3. EZZ Life Science Holdings Limited

EZZ Life Science Holdings Limited

🇦🇺EZZ.AX•ASX

EZZ Life Science Holdings Limited

🇦🇺EZZ.AX•ASX

Your view on EZZ.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About EZZ Life Science Holdings Limited

Industry
Biotechnology
Sector
Healthcare
CEO
Mark Qin
Headquarters
Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
Industry
Biotechnology
Sector
Healthcare
CEO
Mark Qin
Headquarters
Shop 1, 55-59 Parramatta Road, Lidcombe, NSW, AU
Description

EZZ Life Science Holdings Limited, an Australian company, specializes in offering a range of skincare and consumer health products, with its market presence extending across Australia, New Zealand, Mainland China, and other international territories.

The company's operations are divided into two distinct segments: 'Brought in Lines' and 'Company Owned products.' EZZ is actively involved in the wholesale supply of its EAORON-branded skincare portfolio, distributing it to pharmacies, major supermarkets, specialist retailers, and general grocery stores.

Furthermore, the company designs, develops, manufactures, and markets a comprehensive selection of consumer health products under its own EZZ brand. This extensive offering includes vitamins, dietary supplements, sports nutrition, weight management and wellbeing solutions, traditional herbal remedies, and paediatric lines.

These EZZ-branded items are sold directly to consumers via its e-commerce platforms and various retail stores, notably Tmall Global. Founded in 2015, EZZ Life Science Holdings Limited maintains its corporate headquarters in Silverwater, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for EZZ Life Science Holdings Limited. Starting points for EZZ Life Science Holdings Limited: EPS -AUD 0.11, beta 0.91 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for EZZ Life Science Holdings Limited. Trailing twelve-month EPS for EZZ Life Science Holdings Limited stands at -AUD 0.11. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis yearYear to Jun 2027
Average estimateAUD 0.24
Lowest estimateAUD 0.24
Highest estimateAUD 0.24
Number of analysts1
A year ago−AUD 0.111
Growth vs a year ago—

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis yearYear to Jun 2027
Average estimateAUD 105.10M
Lowest estimateAUD 105.10M
Highest estimateAUD 105.10M
Number of analysts1
A year agoAUD 46.28M
Growth vs a year ago+127.1%

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for EZZ Life Science Holdings Limited. EZZ Life Science Holdings Limited has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold EZZ.AX20 companies
Compare EZZ.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ACW.AXActinogen Medical LimitedHealthcareBiotechnology—
ALA.AXArovella Therapeutics LimitedHealthcareBiotechnology—
ATH.AXAlterity Therapeutics LimitedHealthcareBiotechnology—
BIO.AXBiome Australia LimitedHealthcareMedical - Pharmaceuticals—
ILA.AXIsland Pharmaceuticals LimitedHealthcareBiotechnology—
IMU.AXImugene LimitedHealthcareBiotechnology—
PCK.AXPainChek LimitedHealthcareMedical - Healthcare Information Services—
RCE.AXRecce Pharmaceuticals LtdHealthcareBiotechnology—
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
PEPGPepGen Inc.HealthcareNASDAQ$265.3M
PFNDPathfinder Cell Therapy, Inc.HealthcareOTC$66,716
PGENPrecigen, Inc.HealthcareNASDAQ$1.5B
PHARPharming Group N.V.HealthcareNASDAQ$882.4M
PHATPhathom Pharmaceuticals, Inc.HealthcareNASDAQ$430.8M
PHGUFPharming Group N.V.HealthcareOTC$1.1B
PHIOPhio Pharmaceuticals Corp.HealthcareNASDAQ$8.6M
PHMMFPharma Mar, S.A.HealthcareOTC$1.5B
PHRM.CNPharmaTher Holdings Ltd.HealthcareCNQ$9.1M
PHRRFPharmaTher Holdings Ltd.HealthcareOTC$5.3M
PHVSPharvaris N.V.HealthcareNASDAQ$2.2B
PHYOFIXICO plcHealthcareOTC$6.5M
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of EZZ Life Science Holdings Limited.

EZZ.AX AnalysisGood
Past
1
Growth
5
Health
5
Profit
3
Value
4